06127 昭衍新药
按盘价 
9.240 -0.180 (-1.911%) | 2023/12 - 末期 人民币(千) | 与去年末期 比较 | 2022/12 人民币(千) | 2021/12 人民币(千) | 2020/12 人民币(千) | 2019/12 人民币(千) |
非流动资产
| 投资物业 | 0 | -- | 0 | 0 | 0 | 0 |
| 物业、厂房、设备及其他 | 1,303,491 | 5.572% | 1,234,691 | 814,728 | 645,871 | 576,320 |
| 租賃土地 | 0 | -- | 17,794 | 17,794 | 20,831 | 0 |
| 无形资产 | 183,807 | -0.203% | 184,181 | 179,499 | 188,065 | 203,278 |
| 联营公司及共同控制公司权益 | 19,529 | -13.581% | 22,598 | 25,289 | 0 | 0 |
| 其他非流动资产 | 1,398,365 | -53.021% | 2,976,546 | 1,685,283 | 135,448 | 74,624 |
| 2,905,192 | -34.506% | 4,435,810 | 2,722,593 | 990,215 | 854,222 |
流动资产
| 存货 | 184,593 | -47.287% | 350,182 | 106,293 | 91,011 | 49,555 |
| 现金及银行结存 | 2,862,912 | -1.849% | 2,916,848 | 4,154,099 | 308,690 | 176,958 |
| 其他流动资产 | 4,074,462 | 53.096% | 2,661,376 | 1,554,092 | 782,986 | 489,406 |
| 持作出售资产 | 0 | -- | 0 | 0 | 0 | 0 |
| 7,121,967 | 20.133% | 5,928,406 | 5,814,484 | 1,182,687 | 715,919 |
流动负债
| 其他流动负债 | 1,467,365 | -20.436% | 1,844,262 | 1,214,242 | 774,307 | 554,051 |
| 持作出售资产相关负债 | 0 | -- | 0 | 0 | 0 | 0 |
| 1,467,365 | -20.436% | 1,844,262 | 1,214,242 | 774,307 | 554,051 | |
| 流动资产净值 | 5,654,602 | 38.453% | 4,084,144 | 4,600,242 | 408,380 | 161,868 |
| 资产总额减流动负债 | 8,559,794 | 0.468% | 8,519,954 | 7,322,835 | 1,398,595 | 1,016,090 |
非流动负债
| 278,753 | -15.295% | 329,088 | 178,399 | 176,786 | 166,145 |
资本及储备
| 股本 | 749,889 | 39.989% | 535,679 | 381,246 | 227,455 | 161,717 |
| 储备 | 7,529,427 | -1.551% | 7,648,022 | 6,754,968 | 995,089 | 687,483 |
| 其他 | 0 | -- | 0 | 0 | 0 | 0 |
| 股东资金 | 8,279,316 | 1.168% | 8,183,701 | 7,136,214 | 1,222,544 | 849,200 |
| 非控股权益 | 1,725 | -75.925% | 7,165 | 8,222 | (735) | 745 |
| 其他 | 0 | -- | 0 | 0 | 0 | 0 |
| 8,281,041 | 1.101% | 8,190,866 | 7,144,436 | 1,221,809 | 849,945 |
承担及或然负债
| 承担 | -- | -- | 158,578 | 224,929 | 74,268 | 21,476 |
| 或然负债 | -- | -- | 0 | 0 | 0 | 0 |
| 备注： | 实时报价更新时间为25/04/2024 18:00 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | RMB 396,993 |
| 增长率 | -63.045% |
| 每股盈利/(亏损) | RMB 0.530 |
| 每股账面资产净值 (¥) | RMB 11.041 |